期刊文献+

GnRHa对子宫内膜异位症内膜间质细胞生长增殖及血管形成的影响 被引量:10

Effect of GnRHa on the proliferation and angiogenesis of ectopic and eutopic stromal cells
下载PDF
导出
摘要 目的:研究GnRHa对子宫内膜异位症异位及在位内膜间质细胞增殖、凋亡及血管形成的影响。方法:体外原代培养人内异症异位及在位子宫内膜间质细胞,用不同浓度的GnRHa分别干预,四甲基偶氮噻唑蓝(MTT)法测定内膜间质细胞的生长增殖活力;Annexin V-FITC和PI双染、流式细胞仪(FCM)检测异位及在位内膜间质细胞凋亡及周期变化;免疫细胞化学检测血管内皮生长因子(VEGF)表达的改变。结果:GnRHa可抑制内异症异位及在位内膜间质细胞增殖且呈剂量依赖关系;GnRHa能明显增加异位及在位内膜细胞的凋亡率(P<0.05),且异位内膜细胞凋亡率明显高于在位内膜(P<0.05);不同浓度的GnRHa作用后,内膜间质细胞均发生细胞周期阻滞,G1期细胞增加,S期细胞减少,此作用随浓度增加而增强(P<0.05);免疫细胞化学测定表明,GnRHa可降低异位及在位内膜间质细胞VEGF的表达(P<0.05),且随GnRHa浓度增加而增强(P<0.05)。结论:GnRHa可明显抑制人内异症异位及在位子宫内膜间质细胞的生长并促进其凋亡,降低异位及在位内膜间质细胞VEGF的表达。 Objective:To investigate the effect of GnRHa on the proliferation and angiogenesis of ectopic and eutopic endometrial stromal cells from women with endometriosis in vitro. Methods:The ectopic and eutopic endometrial stromal cells were isolated and cultured in vitro, then exposed to different concentration of GnRHa. The growth and proliferation of ectopic and eutopic stromal cells were measured by MTT assay. The cell cycle distribution and apoptosis of ectopic and eutopic endometrial stromal cells were measured by flow cytometry with Annexin V-FITC and PI double staining. The expression of VEGF induced by GnRHa was analyzed by immunocytochemistry. Results:GnRHa could inhibit the proliferation of ectopic and eutopic endometrial stromal cells from women with endometriosis in a dose dependent manner. GnRHa increased the apoptotic rate of both ectopic and eutopic cells, and blocked the cell cycle in a dose dependent manner( P 〈 0.05 ). The apoptotic rate of ectopic cells was absolutely higher than that of eutopic cells. The number of ectopic and eutopic cells were increased in G1 stage and decreased in S stage. The expression of VEGF in ectopic and eutopic cells were significantly decreased after the treatment of GnRHa(P 〈 0.05 ), this action was more significant in the highconcentration group than in the low-concentration group ( P 〈 0.05 ). Conclusion: GnRHa can significantly inhibit the proliferation and enhance the apoptosis of ectopic and eutopic endometrial stromal cells from women with endometriosis, and decrease the expression of VEGF.
出处 《现代妇产科进展》 CSCD 北大核心 2008年第10期737-740,共4页 Progress in Obstetrics and Gynecology
关键词 促性腺素释放激素 在位内膜间质细胞 异位内膜间质细胞 血管内皮生长因子 mal cells Vascular Gonadorelin Eutopic endometrial stromal cell Ectopic endometrial stroendothelial growth factor
  • 相关文献

参考文献17

  • 1Ryan IP, Schriock ED, Taylor RN. Isolationmcharacterization, and comparison of human endometrial and endometriosis cells in vitro[ J]. J Clin Endocriol Metab, 1994,78: 642 -649
  • 2Harada T, Kaponis A, Iwabe T, et al. Apoptosis in human endometrium and endometriosis [ J ]. Hum Reprod Update, 2004,10 : 29-38
  • 3Nishida M, Nasu K, Ueda T, et al. Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis:a possible mechanism involved in the pathogenesis of endometriosis [ J ]. Mol Hum Repord, 2005,11:29-34
  • 4Beliard A, Noel A, Foidart JM. Reduction of apoptosis and proliferation in endometriosis [ J ]. Fertil Steril, 2004,82 : 80 -85
  • 5Mclaren J. Vascular endothelial growth factor and endometriotic angiogenesis[ J]. Hum Report Update ,2000,6:45- 55
  • 6Harmey JH, Bouchier-Hayes D. Vascular endothelial growth factor (VEGF), a survival factor for tumour cells:implications for anti-angiogenic therapy [ J ]. Bioessays, 2002,24 : 280-228
  • 7朱慧莉,黄薇.VEGF在子宫内膜异位症发病机制中的作用[J].现代妇产科进展,2006,15(9):678-680. 被引量:8
  • 8Takehara M, Ueda M, Yamashita Y, et al. Vascular endothelial growth factor A and C gene expression in endometriosis [ J]. Hum Athol,2004,35 : 1369-1375
  • 9Na YJ, Yang SH, Back DW, et al. Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes [ J ]. Hum Reprod,2006,21 : 1846-1855
  • 10王家俊,龚健.细胞凋亡与子宫内膜异位症研究进展[J].国外医学(妇幼保健分册),2005,16(4):243-245. 被引量:1

二级参考文献66

  • 1徐红,欧奇志,况燕,张玮,徐文生.动态检测子宫内膜异位症患者血清血管内皮生长因子的临床意义[J].实用妇产科杂志,2005,21(10):598-600. 被引量:1
  • 2郭海秀,陈向伟.VEGF在子宫内膜异位症中的表达[J].山西医科大学学报,2006,37(1):46-48. 被引量:4
  • 3[1]Tan XJ,Lang JH,Liu DY,et al.Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis.Fertil Steril,2002,78:148-153.
  • 4[3]Ryan IP,Schriock ED,Taylor RN.Isolation,characterization,and comparison of human endometrial and endometriosis cells in vitro.J Clin Endocrinol Metab,1994,78:642-649.
  • 5[4]Taylor RN,Lebovic DI,Mueller MD.Angiogenic factors in endometriosis.Ann N Y Acad Sci,2002,955:89-100.
  • 6[6]Donnez J,Somoes P,Gillerot S,et al.Vascular endothelial growth factor (VEGF) in endometriosis.Hum Reprod,1998,13:1686-1690.
  • 7[7]Vinatier D,Cosson M,Dufour P.Is endometriosis an endometrial disease? Eur J Obstet Gynecol Reprod Biol,2000,91:113-125.
  • 8[8]Vercellini P,Fedele L,Pietropaolo,G,et al.Progestogens for endometriosis:forward to the past.Hum Reprod Update,2003,9:387-396.
  • 9[9]Taylor RN,Lebovic DI,Hornung D,et al.Endocrine and paracrine regulation of endo-metrial angiogenesis.Ann N Y Acad Sci,2001,943:109-121.
  • 10[10]Perrot-Applanat M,Ancelin M,Buteau-Lozano H,et al.Ovarian steroids in endometrial angiogenesis.Steroids,2000,65:599-603.

共引文献31

同被引文献109

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部